Deep Brain Stimulation for Schizophrenia

This trial explores a new treatment called deep brain stimulation (DBS) for individuals with schizophrenia who haven't found relief from other treatments. DBS involves implanting a device that sends electrical signals to specific brain areas, potentially easing persistent symptoms like hearing voices or having strong false beliefs. The researchers aim to assist those who continue to struggle despite trying several medications, including clozapine, often considered the last resort. This trial might suit someone who has had schizophrenia for at least a year with ongoing severe symptoms despite trying various medications. As an unphased trial, this study offers a unique opportunity for patients to explore innovative treatment options that might provide relief when other treatments have failed.

The trial information does not specify if you need to stop taking your current medications. However, since the study involves treatment-resistant schizophrenia, it might be possible that you continue with your current medications unless otherwise directed by the study team.

Research has shown that deep brain stimulation (DBS) holds promise for safely treating conditions like epilepsy, where patients have tolerated it well. Although DBS is not yet approved for schizophrenia, early results suggest it could help without major safety issues. In a small study of seven patients with treatment-resistant schizophrenia, four experienced symptom improvements, indicating the treatment was generally well tolerated.

The trial used the Medtronic Percept with SensSight System, which is considered safe based on data from other applications, provided specific conditions are met. Failure to follow these conditions could lead to risks like tissue damage from heating.

Deep Brain Stimulation (DBS) for schizophrenia is unique because it targets the brain's substantia nigra pars reticulata, a new approach compared to standard treatments like antipsychotic medications, which typically adjust neurotransmitter levels. Researchers are excited about this treatment because DBS offers a non-drug approach that could potentially help people with treatment-resistant schizophrenia, where other options have failed. Unlike medications that take time to adjust and may have side effects, DBS is a direct intervention that could provide more immediate and sustained symptom relief.

Research has shown that deep brain stimulation (DBS) might help some people with schizophrenia that doesn't improve with regular treatments. One study found that almost half of the patients who tried DBS experienced significant improvement. In this trial, participants will receive DBS using the Medtronic Percept with SensSight system, which tracks brain signals and allows doctors to adjust the treatment in real-time. This treatment targets a specific part of the brain to alleviate symptoms like hearing voices or having false beliefs. Early trials are promising, but further research is needed to fully understand its effectiveness.¹²³⁴⁵